A clinical trial for semaglutide, the active ingredient in Ozempic, found that it improved blood sugar control in people with ...

In a small cell therapy trial, 10 out of 12 people with type 1 diabetes no longer needed supplemental insulin, even a year after treatment.

Amanda Smith has kicked insulin to the curb in what experts are calling a milestone in the fight against Type 1 diabetes.

"The medication's going to be 50 percent of your journey, and the other 50 percent is still what you choose to eat and the ...

Most in a small group of patients receiving a stem cell-based infusion no longer needed insulin, but the drug may not suit ...

Swiss company PharmaSens and SiBionics have entered a development partnership for niia signature, an all-in-one wearable that ...

Tsimikas, vice president of San Diego’s Scripps Whittier Diabetes Institute, helped deliver positive news for the estimated 7 million Americans who take insulin every day to manage their type 2 ...

The chief product and customer experience officer said Insulet has seen an uptick in users with Type 2 diabetes since ...

Dr. Lily Ackermann discussed inpatient diabetes care, focusing on real-world decisions and personalized treatment using ...

A novel weight loss drug in the same class as semaglutide has successfully met its targets in its largest clinical trial yet, ...